Literature DB >> 22805173

Fourth ventricular solitary fibrous tumor: a case report and review of the literature.

Congli Wang1, Varsha Manucha, Scott Faro, Michael Weaver, Abir L Mukherjee.   

Abstract

INTRODUCTION: Solitary fibrous tumors of the central nervous system usually present as dura-based masses and clinically resemble meningiomas. There are very few reported cases of intra-ventricular solitary fibrous tumors, particularly in the fourth ventricle. CASE
PRESENTATION: Our patient was a 52-year-old African-American man, who presented to our facility with a two-month history of progressive weakness and numbness in all extremities. A computed tomography scan and brain magnetic resonance imaging scan revealed a homogeneous, avidly enhancing 4.5 × 3.7 × 2.7cm fourth ventricular mass, with compression of adjacent medulla and cerebellum and extension into the foramen of Luschka. Our patient underwent a suboccipital craniotomy and resection of the tumor. A histological examination showed a spindle cell neoplasm with prominent collagenized stroma. The neoplastic cells were strongly and diffusely positive for CD34, vimentin and Bcl-2, and negative for S-100, CD99 and epithelial membrane antigen. The molecular immunology Borstel-1 (MIB-1) proliferation index was low (1%). CD31 immunostain highlighted the endothelial cells but the spindle cells were negative. Reticulin stain demonstrated a moderate reticulin network but individual cells were not invested by reticulin fibers. The histological features and immunoprofile was consistent with a solitary fibrous tumor.
CONCLUSIONS: In the central nervous system, solitary fibrous tumors are usually indolent tumors, with only rare examples showing hypercellularity and increased mitotic activity; features that were absent in our patient's case. We present an uncommon central nervous system neoplasm in a rare location. Although uncommon, solitary fibrous tumors should be included in the differential diagnosis of intra-ventricular tumors in adults.

Entities:  

Year:  2012        PMID: 22805173      PMCID: PMC3423042          DOI: 10.1186/1752-1947-6-205

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Introduction

Solitary fibrous tumors (SFTs) were originally described in pleura and subsequently in soft tissue and many other organs including the central nervous system. SFTs of the central nervous system are rare entities, usually presenting as dura-based masses predominantly in the posterior fossa and spinal region [1]. SFTs are composed of spindle cells in a collagenized stroma with characteristic immunohistochemical features: diffuse and strong reactivity to CD34, positive for vimentin, and often immunoreactive to CD99 and Bcl-2 [1]. Intra-ventricular SFTs are rare, and only six cases have been reported in the fourth ventricle [2-7].

Case presentation

Our patient was a 52-year-old African-American man who presented to our facility with a two-month history of progressive weakness and numbness in all extremities. A computed tomography (CT) scan and a brain magnetic resonance imaging (MRI) scan revealed a 4.5 × 3.7 × 2.7cm, homogeneous, avidly enhancing mass located in the fourth ventricle, compressing adjacent medulla and cerebellum and extending into the foramen of Luschka (Figure 1). Angiography demonstrated multiple dysplastic-appearing branches from the right posterior inferior cerebellar artery supplying the neoplasm.
Figure 1

Contrast-enhanced T1-weighted axial (A) and sagittal (B) magnetic resonance imaging scans showing a homogenous mass located in the fourth ventricle.

Contrast-enhanced T1-weighted axial (A) and sagittal (B) magnetic resonance imaging scans showing a homogenous mass located in the fourth ventricle. Our patient underwent a suboccipital craniotomy and resection of the tumor. During the operation, a cavitron ultrasonic surgical aspirator as well as bipolar cautery and suction were used to debulk the tumor, followed by a combination of RHOTON™ dissectors as well as microscissors to separate the tumor. The entire tumor was successfully removed. Histological examination showed a spindle cell neoplasm with prominent collagenized stroma (Figure 2A). Mitotic figures were not readily found and the molecular immunology Borstel-1 (MIB-1) proliferation index was low (1%). Meningothelial whorls and psammoma bodies were absent. The neoplastic cells were strongly and diffusely positive for CD34 (Figure 2B), vimentin and Bcl-2 (Figure 3A); no immunoreactivity with S-100, CD99 and epithelial membrane antigen (EMA) was detected. A CD31 immunostain highlighted the endothelial cells but not the spindle tumor cells. A moderate reticulin network was demonstrated by reticulin staining, but individual cells were not invested by reticulin fibers (Figure 3B). The histological features and immunoprofile were consistent with SFT.
Figure 2

Photomicrographs (original magnification, 200×). (A) Bland spindle cell tumor with collagenized stroma. (B) Neoplastic cells are strongly immunoreactive to CD34.

Figure 3

Photomicrographs (original magnification, 200×). (A) The tumor cells are immunoreactive to Bcl-2. (B) Neoplastic cells have moderately rich reticulin network.

Photomicrographs (original magnification, 200×). (A) Bland spindle cell tumor with collagenized stroma. (B) Neoplastic cells are strongly immunoreactive to CD34. Photomicrographs (original magnification, 200×). (A) The tumor cells are immunoreactive to Bcl-2. (B) Neoplastic cells have moderately rich reticulin network. Our patient experienced no neurological deficit after surgery, and there were no signs of recurrence at one-year follow-up.

Discussion

Intraventricular tumors can have a wide spectrum of differential diagnosis based on radiological and histopathological features. A bland spindle cell tumor with collagenized stroma and avid contrast enhancement initially suggested a diagnosis of fibroblastic meningioma. However the immunoprofile of the neoplastic cells was typical of a solitary fibrous tumor (negative for EMA, strongly positive for CD34, vimentin and Bcl-2). In contrast, meningiomas are EMA positive and CD34 negative. Hemangiopericytomas can have histological overlap with solitary fibrous tumor, but CD34 and Bcl-2 staining is weak and patchy [8]. To the best of our knowledge, just 17 Intraventricular solitary fibrous tumors have been reported in the literature to date. Six of these tumors were located in the fourth ventricle [2-7], eight cases were in lateral ventricle location [1,9-14], one tumor located in the third ventricle [15], one case occurred in the foramina of Monro [16] and one case was a recurrent SFT arising from the falx cerebri, extending to the bilateral lateral ventricles and the third ventricle [17]. The clinical and radiological features of these tumors are given in Table 1; the immunomorphological features are given in Table 2. The age of patients ranged from 11 to 75 years old, with the vast majority being over 40 years; there was no sex predominance. Based on the available data, all the tumors were less or equal to 5.0 cm in their greatest dimension. On MRI scans, the tumors are typically iso- to hypointense on T1-weighted images, and show intense and homogeneous enhancement after intravenous administration of gadolinium. Most of those SFTs had bland histological features except two tumors showed mild to marked pleomorphism [5,11]. Intraventricular SFTs have an indolent clinical course and excellent prognosis after surgery; however, owing to the small number of cases and limited follow-up, more data is needed to better assess the biological behavior of these tumors and the long-term outcome after treatment.
Table 1

Summary of clinical and radiological features of intraventricular solitary fibrous tumors reported in the literature

ReferenceAge/sexLocationSize (greatest dimension)Imaging featuresFollow-up
Clarençon et al. [2]
32/F
Fourth ventricle
2.5cm
MRI: hypointense T1; heterogeneous- hypointense T2; post-contrast enhancement
NA
Cummings et al. [3]
52/M
Fourth ventricle
NA
MRI: homogeneous post-contrast enhancement
Autopsy
Gessi et al. [4]
63/F
Fourth ventricle
2cm
MRI: isointense T1; partial post-contrast enhancement
NA
Kim et al. [5]
49/F
Fourth ventricle
NA
MRI: dense post-contrast enhancement
No recurrence after one year
Montano et al. [6]
61/M
Fourth ventricle
NA
MRI: hypointense T1; iso-hypointense T2; marked post-contrast enhancement
No recurrence after two years
Sawauchi et al. [7]
57/M
Fourth ventricle
NA
MRI: low intensity T1; homogeneous post-contrast enhancement
NA
Tihan et al. [1]*
NA
Lateral ventricle
NA
MRI: low density T1; post-contrast enhancement
NA
Clarençon et al. [9]
44/F
Right lateral ventricle
4.0cm
MRI: hypointense T1; hyperintense T2; thin peripheral enhancement of multiple confluent cysts post-contrast
NA
Liao et al. [10]
NA
Right lateral ventricle
NA
NA
NA
Mekni et al. [11]
40/M
Right lateral ventricle
3.5cm
NA
No recurrence after three years
Surendrababu et al. [12]
55/F
Left lateral ventricle
5.0cm
NA
No recurrence after one year
Vassal et al. [13]
60/F
Left lateral ventricle
5.0cm
MRI: lobulated mass; homogeneous post-contrast enhancement
No recurrence after two years
Wright et al. [14]
11/F
Right lateral ventricle
NA
NA
NA
Koçak et al. [15]
63/M
Third ventricle
2.5cm
MRI: isointense T1 and T2; significant post-contrast enhancement
No recurrence after three and a half years
Kinfe et al. [16]
75/F
Foramen of Monro
2.5cm
CT: Hypointense tumor at the foramina of Monro; homogeneous post-contrast enhancement
No recurrence after one year
Teranishi et al. [17]
61/M
Falx cerebri, extended to bilateral lateral ventricles and the third ventricle
NA
MRI: isointense T1; iso-hyperintense T2; heterogeneous post-contrast enhancement
NA
Present case52/MFourth ventricle4.5cmIso-hypointense T1; heterogeneous T2; homogeneous post-contrast enhancementNo recurrence after one year

*Two cases.

NA = not available.

MRI=magnetic resonance imaging.

Table 2

Summary of immunomorphological features of intraventricular solitary fibrous tumors reported in the literature

ReferenceHistologic features
Immunohistochemical features
PleomorphismMitosisNecrosisCD 34Bcl-2VimentinS-100EMAMIB-1Reticulin
Clarençon et al. [2]
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Cummings et al. [3]
NA
NA
NA
Strong, diffuse +
Strong, diffuse +
Strong, diffuse +
-
-
NA
NA
Gessi et al. [4]
NA
Absent
Absent
Strong +
Strong +
Strong +
-
-
<2%
NA
Kim et al. [5]
Mild
Rare
NA
Diffuse +
NA
NA
-
-
<3%
Outlining of individual cells -
Montano et al. [6]
NA
NA
NA
+
+
+
-
-
<1%
NA
Sawauchi et al. [7]
NA
NA
NA
+
NA
+
NA
NA
NA
NA
Tihan et al. [1]*
NA
NA
NA
Strong +
NA
Strong +
-
-
NA
Overall highlighted only the coarse collagen background
Clarençon et al. [9]
NA
NA
NA
Strong +
NA
NA
NA
NA
NA
NA
Liao et al. [10]
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Mekni et al. [11]
Marked
5/10 HPF
Focal
Strong +
+
Strong +
NA
NA
<2%
NA
Surendrababu et al.[12]
Absent
NA
NA
+
+
+
-
-
<2%
NA
Vassal et al. [13]
Absent
Absent
Absent
Diffuse +
NA
Diffuse +
-
-
<2%
NA
Wright et al. [14]
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Koçak et al. [15]
NA
NA
NA
Focal +
Diffuse +
NA
-
-
1%
Interlacing reticular fibers +
Kinfe et al. [16]
NA
NA
NA
Strong +
Strong +
Strong +
-
-
<1%
Rich network of reticular fibers
Teranishi et al. [17]
NA
NA
NA
Strong +
NA
+
-
-
5%
NA
Present caseAbsentAbsentAbsentStrong, diffuse +Strong, diffuse +Strong, diffuse +--1%Reticulin network moderate +; individual cells -

*Two cases.

HPF = high power field; NA = not available; + = positive; - = negative.

Summary of clinical and radiological features of intraventricular solitary fibrous tumors reported in the literature *Two cases. NA = not available. MRI=magnetic resonance imaging. Summary of immunomorphological features of intraventricular solitary fibrous tumors reported in the literature *Two cases. HPF = high power field; NA = not available; + = positive; - = negative.

Conclusions

We report a rare case of SFT in an unusual location. Though rare, SFTs should be considered in the histological differential diagnosis of intra-ventricular tumors particularly, spindle cell tumors with collagenized stroma, along with meningioma and schwannoma.

Consent

Written informed consent was obtained from the patient for publication of this manuscript and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CW performed the gross examination of the specimen, conceived the case report, searched the literature and drafted the manuscript. VM performed the histopathological evaluation of the slides and made substantial revisions to the manuscript. SF conducted the radiology examinations and made revisions to the manuscript. MW operated on our patient and made revisions to the manuscript. AM performed the histopathological evaluation of the slides and critical analyzed the manuscript. All authors read and approved the final manuscript.
  17 in total

1.  Solitary fibrous tumour of the IV ventricle.

Authors:  Nicola Montano; Francesco Doglietto; Libero Lauriola; Francesco Signorelli; Roberto Pallini
Journal:  Br J Neurosurg       Date:  2010-08       Impact factor: 1.596

2.  Intraventricular solitary fibrous tumor: a rare location for a rare tumor.

Authors:  Marco Gessi; Liverana Lauretti; Eduardo Fernandez; Libero Lauriola
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

3.  [Solitary fibrous tumor of right ventricle: report of a case].

Authors:  Qiu-Lin Liao; Ri-Quan Lai
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2009-10

4.  Solitary fibrous tumors of the central nervous system: report of five cases with unusual clinicopathological and outcome patterns.

Authors:  François Vassal; Romain Manet; Fabien Forest; Jean Phillipe Camdessanche; Michel Péoc'h; Christophe Nuti
Journal:  Acta Neurochir (Wien)       Date:  2010-11-10       Impact factor: 2.216

5.  Intraventricular solitary fibrous tumor: an unusual tumor with radiological, ultrastructural, and immunohistochemical evaluation: case report.

Authors:  Ayhan Koçak; Süleyman Rüştü Cayli; Kaya Saraç; Nasuhi Engin Aydin
Journal:  Neurosurgery       Date:  2004-01       Impact factor: 4.654

6.  CD34 and dural fibroblasts: the relationship to solitary fibrous tumor and meningioma.

Authors:  T J Cummings; J L Burchette; R E McLendon
Journal:  Acta Neuropathol       Date:  2001-10       Impact factor: 17.088

7.  [Solitary fibrous tumor of the fourth ventricle: case report].

Authors:  Satoshi Sawauchi; Hideki Arakawa; Keisuke Taya; Tohru Terao; Hiromichi Nakazaki; Robert Tomohiko Numoto; Yoshitaro Yamaguchi; Takuo Hashimoto; Yutaka Yamaguchi; Toshiaki Abe
Journal:  No Shinkei Geka       Date:  2003-05

8.  Solitary fibrous tumour of the central nervous system: pathological study of eight cases and review of the literature.

Authors:  Amina Mekni; Jihene Kourda; Karim Ben Hammouda; Monia Tangour; Nidhameddine Kchir; Moncef Zitouna; Slim Haouet
Journal:  Pathology       Date:  2009       Impact factor: 5.306

9.  Solitary fibrous tumor of the foramen of Monro.

Authors:  Thomas M Kinfe; Christoph A Tschan; Alexandru C Stan; Joachim K Krauss
Journal:  Clin Neurol Neurosurg       Date:  2008-02-20       Impact factor: 1.876

10.  Unusual presentations of cerebral solitary fibrous tumors: report of four cases.

Authors:  K Anthony Kim; Ignacio Gonzalez; J Gordon McComb; Steven L Giannotta
Journal:  Neurosurgery       Date:  2004-04       Impact factor: 4.654

View more
  3 in total

1.  Magnetic resonance features of meningeal solitary fibrous tumors.

Authors:  Xi Li; Lilian Tan; Xiaoming Ouyang; Jindai Jiang; Sumeng Huang; Yong Huang; Shuxin Li; Deji Chen
Journal:  Oncol Lett       Date:  2018-04-04       Impact factor: 2.967

Review 2.  A solitary fibrous tumor/hemangiopericytoma of the fourth ventricle: case report and literature review.

Authors:  Han Yang; Yuxin Zhang; Ting Zheng; Cao Li; Guangcai Tang; Guangxiang Chen
Journal:  J Int Med Res       Date:  2019-11-17       Impact factor: 1.671

3.  Retroperitoneal solitary fibrous tumor of the pelvis with pollakiuria: a case report.

Authors:  Takaaki Tsushimi; Takaharu Yagi; Naobumi Tomozawa; Hiromi Ohnishi
Journal:  BMC Res Notes       Date:  2012-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.